Supervised on-site dosing in injectable opioid agonist treatment-considering the patient perspective. Findings from a cross-sectional interview study in two German cities

Abstract Background Injectable opioid agonist treatment (iOAT) is an effective option to support people living with opioid use disorder (OUD) who have not sufficiently benefitted from oral OAT. However, iOAT has been criticised based on theoretical and practical grounds for its dosing policies: Curr...

詳細記述

書誌詳細

主要な著者:	Zoe Friedmann, Hans-Tilmann Kinkel, Claudia Kühner, Andreas Zsolnai, Inge Mick, Annette Binder
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMC 2023-11-01
シリーズ:	Harm Reduction Journal
主題:	Injectable opioid agonist treatment Opioid use disorder Take-home doses Dosing policies Patient perspective Qualitative research
オンライン･アクセス:	https://doi.org/10.1186/s12954-023-00896-6
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!